SMAD4 and TGFβ are architects of inverse genetic programs during fate determination of antiviral CTLs.
Saved in:
| Title: | SMAD4 and TGFβ are architects of inverse genetic programs during fate determination of antiviral CTLs. |
|---|---|
| Authors: | Chandiran K; Department of Immunology, University of Connecticut Health Center, Farmington, United States., Suarez-Ramirez JE; Department of Immunology, University of Connecticut Health Center, Farmington, United States., Hu Y; Department of Microbiology and Immunology, Emory Vaccine Center, Emory University, Atlanta, United States., Jellison ER; Department of Immunology, University of Connecticut Health Center, Farmington, United States., Ugur Z; Department of Immunology, University of Connecticut Health Center, Farmington, United States., Low JS; Department of Immunobiology, Yale University School of Medicine, New Haven, United States., McDonald B; NOMIS Center for Immunobiology and Microbial Pathogenesis, Salk Institute for Biological Studies, La Jolla, United States., Kaech SM; NOMIS Center for Immunobiology and Microbial Pathogenesis, Salk Institute for Biological Studies, La Jolla, United States., Cauley LS; Department of Immunology, University of Connecticut Health Center, Farmington, United States. |
| Source: | ELife [Elife] 2022 Aug 09; Vol. 11. Date of Electronic Publication: 2022 Aug 09. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: eLife Sciences Publications, Ltd Country of Publication: England NLM ID: 101579614 Publication Model: Electronic Cited Medium: Internet ISSN: 2050-084X (Electronic) Linking ISSN: 2050084X NLM ISO Abbreviation: Elife Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
